Validation of Fatty Liver Scoring Systems for the Diagnosis of NAFLD in Adolescents
A team of investigators sought to identify the accuracy of diagnostic tools for the detection of nonalcoholic fatty liver disease in adolescent patients.
Metabolic Liver Disease
METABOLIC LIVER DISEASE
Latest Articles
Lifestyle Modification for Nonalcoholic Fatty Liver Disease: An AGA Clinical Practice Update
The American Gastroenterological Association commissioned an expert review to identify best practice advice for treating patients with nonalcoholic fatty liver disease.
Carbohydrate-Restricted Diet Superior to Low-Calorie Diet for Reducing Hepatic Triglyceride Content in Children With NAFLD
Investigators compared a carbohydrate-restricted diet with a low-calorie diet to determine which more effectively reduced hepatic triglyceride content in children with nonalcoholic fatty liver disease.
‘Significant’ Excess Mortality Risk Seen Across All NAFLD Stages
Investigators studied the risk of overall and cause-specific mortality across the histological spectrum in individuals with non-alcoholic fatty liver disease.
Increase in Incidence of Pediatric NAFLD Cases Seen Between 2009 and 2018
From 2009 to 2018, there was an increase in the incidence of nonalcoholic fatty liver disease among children, although many NAFLD cases remain undiagnosed.
Early Adulthood Weight Gain in Women Identified as Potential NAFLD Risk Factor
Investigators studied the impact of changes in adiposity over patients’ life courses on the midlife development of nonalcoholic fatty liver disease.
Very Low-Calorie Diet Feasible Treatment for Nonalcoholic Fatty Liver Disease
Investigators sought to determine whether a very low-calorie diet is feasible and acceptable to achieve and maintain a weight loss of 10% or more in patients with nonalcoholic fatty liver disease.
CPAP Therapy Does Not Appear to Improve Nonalcoholic Fatty Liver Disease in OSA
The use of CPAP alone does not appear to improve hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease and obstructive sleep apnea.
FDA Fast Tracks SSAO Inhibitor for Nonalcoholic Steatohepatitis
TERN-201 is a highly-selective semicarbazide-sensitive amino oxidase inhibitor.
Novel Biomarker Panel May Allow for Noninvasive Non-Alcoholic Steatohepatitis Diagnosis
The NIS4 biomarker panel may provide a means for clinicians to avoid unnecessary liver biopsies in patients at low risk for NASH.
Significant Subset of Children With NAFLD Progress to Definite NASH, Fibrosis, and Diabetes
A team of investigators studied the relationship between changes in liver histology and changes in body mass index, dyslipidemia, and measures of glucose homeostasis in children.
Women at Lower Risk for Nonalcoholic Fatty Liver Disease But at Greater Risk for Progression
A systematic review and meta-analysis of observational studies was conducted to assess the prevalence of nonalcoholic fatty liver disease in the general population.
Updates on NAFLD: Is FMT the Treatment of the Future?
As the role of the gut microbiome in nonalcoholic fatty liver disease is explored, research has turned to fecal microbiota transplantation as a potential treatment option.
Subclinical Hypothyroidism in NAFLD Is Associated With All-Cause and Cardiovascular Mortality
Low thyroid function is associated with nonalcoholic fatty liver disease and predicted all-cause and cardiovascular mortality in this population.
Risk for Maternal, Neonatal Complications Increased With NAFLD
Women with non-alcoholic fatty liver disease have increased risks for maternal and neonatal complications.
World Trade Center First Responders have Increased Prevalence of Hepatic Steatosis
First responders to the World Trade Center attacks appear to have a much higher prevalence of hepatic steatosis than the general population.
Intravenous Choline Chloride Fast-Tracked for Intestinal Failure-Associated Liver Disease
The FDA has granted Fast Track designation to intravenous choline chloride (Protara Therapeutics), an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease.
Women Have Lower Overall Risk for NAFLD, But Higher Risk for Advanced Fibrosis
Women have a lower overall risk of acquiring nonalcoholic fatty liver disease (NAFLD) than men do, but a higher risk of advanced fibrosis if NAFLD status is confirmed.
Liver Forum Releases Recommendations on Diet, Exercise in NAFLD/NASH
The lack of standardized diet and exercise recommendations across NAFLD/NASH clinical trials has posed a significant challenge in understanding their impact.
Liver Forum Releases Guidelines for Assessing Patients with NASH
The first guidelines for assessing the eligibility of patients with NASH for inclusion in clinical studies were released.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
